Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06484088 · ClinicalTrials.gov registry record · Early Phase 1

Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers

A Early Phase 1 study of Irritability, sponsored by National Institute of Mental Health (NIMH).

Recruiting
Registry status
Early Phase 1
Development phase
80
Enrollment target
2
Study locations

NCT06484088 is a Early Phase 1 study of Irritability that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 80 participants, below the 134-participant average among 3 other Irritability trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06484088, a Early Phase 1 study of Irritability, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).

RECRUITING
Registry status
Early Phase 1
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

Background: Irritability can be defined as an unusually strong response to frustration; these responses may include severe temper outbursts and a constant grumpy mood. Irritability is a common symptom of many mental health disorders. Little is known about how the brain responds to frustration, and few treatments are available for this problem. Researchers want to know more about how the brain responds to frustration. Objective: To learn how the brain responds to frustration. Eligibility: Healthy adults aged 18 to 55 years. They must have been screened through studies 01-M-0254 or 17-M-0181. Design: Participants will have up to 3 study visits in 2 months. Each visit will last up to 4 hours. Visit 1: Participants will be screened. They will have a physical exam. They will complete questionnaires about how often and how easily they get angry or grumpy. They will be trained to use a device that measures hand grip. Visit 2: Participants will have a magnetic resonance imaging (MRI) scan. They will lie on a table that slides into a tube. Padding will hold their head still. Visit 3: Participants will undergo magnetoencephalography (MEG). A cone with detectors will be lowered over their head while they are seated. The MEG will measure the magnetic fields in the participant s brain both while they are resting and while they are doing the frustration task. For the task, they will hold a grip device in each hand. They will use the devices to pick 1 of 2 doors on a computer screen. The task has 3 parts. The participant s face will be filmed during this task.

Conditions Studied

Interventions

  • OTHER Frustration task

Study Locations (2)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Texas

  • Texas A&M University - College Station

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-02-21
Est. Completion 2027-08-31
Phase Early Phase 1

What the Registry Record Tells You About NCT06484088

The ClinicalTrials.gov registry entry for NCT06484088 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 134-participant average among 3 other Irritability trials with a reported enrollment target (40% lower). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Irritability appearing as the primary indexed condition, and to 1 intervention - of which Frustration task is the first listed.

NCT06484088 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Texas.

Frequently Asked Questions

What is clinical trial NCT06484088 about?

NCT06484088 is a clinical study titled "Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers". Background: Irritability can be defined as an unusually strong response to frustration; these responses may include severe temper outbursts and a constant grumpy mood. Irritability is a common symptom of many mental health disorders. Little is known about how the brain responds to frustration, and ...

What is the current status of trial NCT06484088?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2025-02-21. Estimated completion is 2027-08-31.

What conditions does trial NCT06484088 study?

This clinical trial studies the following conditions: Irritability.

What interventions are being tested in trial NCT06484088?

The interventions under investigation include: Frustration task (OTHER).

Who is sponsoring clinical trial NCT06484088?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06484088 being conducted?

This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.